[{"id":"d2877394-e213-4c25-a096-d4817f03b792","acronym":"","url":"https://clinicaltrials.gov/study/NCT03685409","created_at":"2022-06-12T22:55:04.110Z","updated_at":"2024-07-02T16:37:06.549Z","phase":"Phase 3","brief_title":"Cancer Chemoprevention by Metformin Hydrochloride in Oral Potentially Malignant Lesions","source_id_and_acronym":"NCT03685409","lead_sponsor":"Cairo University","biomarkers":" CCND1 • MIR200","pipe":"","alterations":" ","tags":["CCND1 • MIR200"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e metformin"],"overall_status":"Unknown status","enrollment":" Enrollment 62","initiation":"Initiation: 10/01/2018","start_date":" 10/01/2018","primary_txt":" Primary completion: 09/30/2019","primary_completion_date":" 09/30/2019","study_txt":" Completion: 09/30/2020","study_completion_date":" 09/30/2020","last_update_posted":"2018-09-26"}]